The Potential of Candesartan to Retard the Progression of Aortic Stenosis

NCT00699452 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Aortic Valve Stenosis

Interventions

DRUG: candesartan
DRUG: placebo

Sponsor

University of Helsinki

Collaborators

[object Object]